CRISPR-Cas9 is a promising technology for genome editing. Here we use Cas9 nuclease-induced
double-strand break DNA (DSB) at the UROS locus to model and correct congenital …

Nucleoside diphosphate kinases (NDPK) are encoded by the NME genes, also called NM23.
They catalyze the transfer of γ-phosphate from nucleoside triphosphates to nucleoside …

Background Coronavirus disease 2019 (COVID-19)-associated acute kidney injury (AKI)
frequency, severity and characterization in critically ill patients has not been reported. Methods …

The presence of circulating tumor cells (CTCs) and CTC clusters, also known as tumor
microemboli, in biological fluids has long been described. Intensive research on single CTCs has …

CRISPR-Cas9 is a promising technology for gene therapy. However, the ON-target genotoxicity
of CRISPR-Cas9 nuclease due to DNA double-strand breaks has received little attention …

Inhibitor of DNA binding (Id) proteins bind to and inhibit the function of basic helix-loop-helix
(bHLH) transcription factors including those that regulate pancreatic development. Moreover…

Purpose: Expediting the diagnosis of pancreatic ductal adenocarcinoma (PDAC) would
benefit care management, especially for the start of treatments requiring histological evidence. …

CRISPR-Cas9 is a highly promising technology for clinical development. However, this
powerful tool can induce adverse genomic events. The off-target genotoxicity is well described, …

Tumor-released extracellular vesicles (EVs) contain tumor-specific cargo distinguishing
them from healthy EVs, and making them eligible as circulating biomarkers. Glypican 1 (GPC1)-…

Pancreatic cancer is a public health problem because of its increasing incidence, the absence
of early diagnostic tools, and its aggressiveness. Despite recent progress in chemotherapy…